Startseite Point-of-care testing: revolutionizing clinical biochemistry using decentralized diagnostics
Artikel
Lizenziert
Nicht lizenziert Erfordert eine Authentifizierung

Point-of-care testing: revolutionizing clinical biochemistry using decentralized diagnostics

  • Simran Shaikh ORCID logo , Sanjyoti A. Panchbudhe ORCID logo , Rajni R. Shivkar ORCID logo , Arnab Banerjee ORCID logo , Paulami Deshmukh ORCID logo und Charushila Y. Kadam ORCID logo EMAIL logo
Veröffentlicht/Copyright: 4. April 2025

Abstract

Point-of-care testing (POCT) refers to decentralized testing done using complex but compact, portable devices that can be done near the site at the patient’s bedside. These enable quick diagnosis and timely intervention because turnaround time (TAT) decreases with these devices. They can also be operated by non-medical personnel and patients with minimum expertise as these devices are easy to handle and interpret. This increases patient awareness regarding their diseases and benefits doctors in giving more patient-centered care. POCT devices require minimum setup and can be utilized even in remote places. The present review focuses on POCT devices employed specifically in clinical biochemistry, e.g., glucose, HbA1c, cardiac biomarkers, fertility tests, hematological analysis, electrolytes, enzymes, urine dipstick tests, etc. This introductory review delves into comprehending the fundamentals of POCT technologies, their guidelines, applications, advantages, and disadvantages. It covers a broad overview of the tests done and the samples required to process these tests. It also compares the pros and cons of POCT devices over centralized laboratory testing. The review also aims to emphasize the relevance of its use in today’s era, current trends regarding POCT in urban and rural setups, challenges faced in the field during its implementation, and the potential areas of improvement in the future. However, it is advisable to seek references for more detailed and critical information regarding all the specific topics given in this review article.


Corresponding author: Charushila Y. Kadam, Professor, Department of Biochemistry, Sukh Sagar Medical College and Hospital, Jabalpur, 482003, Madhya Pradesh, India, E-mail:

Acknowledgments

The authors would like to acknowledge administrative support from the Department of Biochemistry, Smt. Kashibai Navale Medical College and General Hospital (Narhe, Pune-411041, Maharashtra, India), Department of Physiology (UG & PG), Serampore College (9, William Carey Road, Serampore, Hooghly-712201, West Bengal, India), and Department of Biochemistry, Sukh Sagar Medical College and Hospital (Jabalpur-482003, Madhya Pradesh, India). Figure 2 was drawn using the BioRender.com online tool.

  1. Research ethics: Not applicable.

  2. Informed consent: Not applicable.

  3. Author contributions: All authors have affirmed their submission and accepted responsibility for the whole content of this submitted work. S.S. and S.A.P. were responsible for the concept, writing the original draft, and reviewing it for confirmation of submission. R.R.S., A.B., and P.D. were equally responsible for writing the original draft, formal analysis, and finally reviewing the final draft of the manuscript. C.Y.K. was responsible for the concept, writing and reviewing the original draft, and final approval for submission of the manuscript.

  4. Use of Large Language Models, AI and Machine Learning Tools: None declared.

  5. Conflict of interest: The authors state no conflict of interest.

  6. Research funding: None declared.

  7. Data availability: Not applicable.

References

1. Astier, A, Carlet, J, Hoppe-Tichy, T, Jacklin, A, Jeanes, A, McManus, S, et al.. What is the role of technology in improving patient safety? A French, German, and UK healthcare professional perspective. J Patient Saf Risk Manag 2020;25:219–24. https://doi.org/10.1177/2516043520975661.Suche in Google Scholar

2. Olver, P, Bohn, MK, Adeli, K. Central role of laboratory medicine in public health and patient care. Clin Chem Lab Med 2022;61:666–73. https://doi.org/10.1515/cclm-2022-1075.Suche in Google Scholar PubMed

3. Market insights. https://www.techsciresearch.com/report/india-diagnostic-labs-market/7649.html [Accessed 30 May 2024].Suche in Google Scholar

4. WHO publishes new essential diagnostics list and urges countries to prioritize investments in testing. https://www.who.int/news/item/29-01-2021-who-publishes-new-essential-diagnostics-list-and-urges-countries-to-prioritize-investments-in-testing [Accessed 26 May 2024].Suche in Google Scholar

5. Strengthening clinical laboratories by CDC. https://www.cdc.gov/csels/dls/strengthening-clinical-labs.html#print [Accessed May 26, 2024].Suche in Google Scholar

6. Ministry of health and family welfare – statistics division – rural health statistics 2018–19: https://main.mohfw.gov.in/sites/default/files/Final%20RHS%202018-19_0.pdf [Accessed 28 May 2024].Suche in Google Scholar

7. Anticona Huaynate, CF, Pajuelo Travezaño, MJ, Correa, M, Mayta Malpartida, H, Oberhelman, R, Murphy, LL, et al.. Diagnostics barriers and innovations in rural areas: insights from junior medical doctors on the frontlines of rural care in Peru. BMC Health Serv Res 2015;15:454. https://doi.org/10.1186/s12913-015-1114-7.Suche in Google Scholar PubMed PubMed Central

8. Kost, GJ. “1. Goals, guidelines and principles for point-of-care testing. In: Principles & practice of point-of-care testing. Hagerstwon, MD: Lippincott Williams & Wilkins; 2002:3–12 pp.Suche in Google Scholar

9. Nichols, JH. Utilizing point-of-care testing to optimize patient care. EJIFCC 2021;32:140–4.Suche in Google Scholar

10. Chaisirin, W, Wongkrajang, P, Thoesam, T, Praphruetkit, N, Nakornchai, T, Riyapan, S, et al.. Role of point-of-care testing in reducing time to treatment decision-making in urgency patients: a randomized controlled trial. West J Emerg Med 2020;21:404–10. https://doi.org/10.5811/westjem.2019.10.43655.Suche in Google Scholar PubMed PubMed Central

11. Rooney, KD, Schilling, UM. Point-of-care testing in the overcrowded emergency department--can it make a difference? Crit Care 2014;18:692. https://doi.org/10.1186/s13054-014-0692-9.Suche in Google Scholar PubMed PubMed Central

12. Collinson, PO. The need for a point of care testing: an evidence-based appraisal. Scand J Clin Lab Invest Suppl 1999;230:67–73. https://doi.org/10.1080/00365519909168329.Suche in Google Scholar

13. Rossi, AF, Khan, D. Point of care testing: improving pediatric outcomes. Clin Biochem 2004;37:456–61. https://doi.org/10.1016/j.clinbiochem.2004.04.004.Suche in Google Scholar PubMed

14. Price, CP. Point-of-care testing. Impact on medical outcomes. Clin Lab Med 2001;21:285–303. https://doi.org/10.1016/s0272-2712(18)30035-0.Suche in Google Scholar

15. Patzer, KH, Ardjomand, P, Göhring, K, Klempt, G, Patzelt, A, Redzich, M, et al.. Implementation of HbA1c point of care testing in 3 German medical practices: impact on workflow and physician, staff, and patient satisfaction. J Diabetes Sci Technol 2018;12:687–94. https://doi.org/10.1177/1932296818759690 [Epub 2018 Mar 13].Suche in Google Scholar PubMed PubMed Central

16. Gallichan, M. Self monitoring of glucose by people with diabetes: evidence based practice. BMJ 1997;314:964–7. https://doi.org/10.1136/bmj.314.7085.964.Suche in Google Scholar PubMed PubMed Central

17. Timeline portraying the history of pregnancy tests. https://history.nih.gov/display/history/Pregnancy+Test+Timeline#:∼:text=Nineteenth%20Century&text=Scientists%20did%20not%20know%20enough,(such%20as%20morning%20sickness) [Accessed 28 May 2024].Suche in Google Scholar

18. From benchtop to bedside: moving solutions from lab to point of care. –https://www.labcompare.com/10-Featured-Articles/596871-From-Benchtop-to-Bedside-Moving-Solutions-from-the-Lab-to-Point-of-Care/?catid=5096 [Accessed 28 May 2024].Suche in Google Scholar

19. Role of continuous glucose monitoring in diabetes treatment. Arlington (VA): American Diabetes Association; 2018.Suche in Google Scholar

20. Erasmus, R, Sahni, S, El-Sharkawy, R. Connectivity strategies in managing a POCT service. EJIFCC 2021;32:190–4.Suche in Google Scholar

21. Bodington, R, Kassianides, X, Bhandari, S. Point-of-care testing technologies for the home in chronic kidney disease: a narrative review. Clin Kidney J 2021;14:2316–31. https://doi.org/10.1093/ckj/sfab080.Suche in Google Scholar PubMed PubMed Central

22. Luppa, PB, Müller, C, Schlichtiger, A, Schlebusch, H. Point-of-care testing (POCT): current techniques and future perspectives. Trends Analyt Chem 2011;30:887–98. https://doi.org/10.1016/j.trac.2011.01.019 [Epub 2011 Mar 21].Suche in Google Scholar PubMed PubMed Central

23. Nichols, JH. Management of point-of-care testing. 1999. Article https://acutecaretesting.org/-/media/acutecaretesting/files/pdf/management-of-pointofcare-testing.pdf [Accessed 28 May 2024].Suche in Google Scholar

24. Schembri, CT, Ostoich, V, Lingane, PJ, Burd, TL, Buhl, SN. Portable simultaneous multiple analyte whole-blood analyzer for point-of-care testing. Clin Chem 1992;38:1665–70. https://doi.org/10.1093/clinchem/38.9.1665.Suche in Google Scholar

25. Park, HD. Current status of clinical application of point-of-care testing. Arch Pathol Lab Med 2021;145:168–75. https://doi.org/10.5858/arpa.2020-0112-RA.Suche in Google Scholar PubMed

26. Lisa-Jean, C. The pros and cons of point-of-care testing vs laboratory testing. https://www.mlo-online.com/continuing-education/article/13017084/the-pros-and-cons-of-pointofcare-testing-vs-laboratory-testing [Accessed 28 May 2024].Suche in Google Scholar

27. Neogi, SS, Mehndiratta, M, Gupta, S, Puri, D. Pre- analytical phase in clinical chemistry laboratory. J Clin Sci Res 2016;5:171–8. https://doi.org/10.15380/2277-5706.JCSR.15.062.Suche in Google Scholar

28. Cadamuro, J, Simundic, AM. The preanalytical phase – from an instrument-centred to a patient-centred laboratory medicine. Clin Chem Lab Med 2022;61:732–40. https://doi.org/10.1515/cclm-2022-1036.Suche in Google Scholar PubMed

29. Florkowski, C, Don-Wauchope, A, Gimenez, N, Rodriguez-Capote, K, Wils, J, Zemlin, A. Point-of-care testing (POCT) and evidence-based laboratory medicine (EBLM) – does it leverage any advantage in clinical decision making? Crit Rev Clin Lab Sci 2017;54:471–94. https://doi.org/10.1080/10408363.2017.1399336 [Epub 2017 Nov 23].Suche in Google Scholar PubMed

30. Patel, K, Suh-Lailam, BB. Implementation of point-of-care testing in a pediatric healthcare setting. Crit Rev Clin Lab Sci 2019;56:239–46. https://doi.org/10.1080/10408363.2019.1590306 [Epub 2019 Apr 11].Suche in Google Scholar PubMed

31. Larsson, A, Greig-Pylypczuk, R, Huisman, A. The state of point-of-care testing: a European perspective. Upsala J Med Sci 2015;120:1–10. https://doi.org/10.3109/03009734.2015.1006347 [Epub 2015 Jan 26].Suche in Google Scholar PubMed PubMed Central

32. Price, CP. Point of care testing. BMJ 2001;322:1285–8. https://doi.org/10.1136/bmj.322.7297.1285.Suche in Google Scholar PubMed PubMed Central

33. CLIA guidelines. https://www.fda.gov/medical-devices/ivd-regulatory-assistance/clinical-laboratory-improvement-amendments-clia (Accessed 26 May 2024].Suche in Google Scholar

34. CLIA test complexities. https://www.cdc.gov/clia/test-complexities.html [Accessed 28 May 2024)Suche in Google Scholar

35. Burtis, C, Ashwood, E, Bruns, D. Tietz textbook of clinical chemistry and molecular diagnostics, 5th ed. St Louis, Missouri, USA: Elsevier; 2012.Suche in Google Scholar

36. Land, KJ, Boeras, DI, Chen, XS, Ramsay, AR, Peeling, RW. REASSURED diagnostics to inform disease control strategies, strengthen health systems and improve patient outcomes. Nat Microbiol 2019;4:46–54. https://doi.org/10.1038/s41564-018-0295-3 [Epub 2018 Dec 13].Suche in Google Scholar PubMed PubMed Central

37. ASSURED guidelines by WHO. https://www.who.int/teams/sexual-and-reproductive-health-and-research-(srh)/areas-of-work/sexual-health/sexually-transmitted-infections/point-of-care-tests [Accessed May 28, 2024].Suche in Google Scholar

38. St John, A, Price, CP. Existing and emerging technologies for point-of-care testing. Clin Biochem Rev 2014;35:155–67.Suche in Google Scholar

39. Fung, AWS. Utilizing connectivity and data management system for effective quality management and regulatory compliance in point of care testing. Pract Lab Med 2020;22:e00187. https://doi.org/10.1016/j.plabm.2020.e00187.Suche in Google Scholar PubMed PubMed Central

40. Laurence, CO, Moss, JR, Briggs, NE, Beilby, JJ, PoCT Trial Management Group. The cost-effectiveness of point of care testing in a general practice setting: results from a randomised controlled trial. BMC Health Serv Res 2010;10:165. https://doi.org/10.1186/1472-6963-10-165.Suche in Google Scholar PubMed PubMed Central

41. A Gatlin, CL, Kleemann, GR, Hays, LG, Link, AJ, Yates, JR3rd. Protein identification at the low femtomole level from silver-stained gels using a new fritless electrospray interface for liquid chromatography-microspray and nanospray mass spectrometry. Anal Biochem 1998;263:93–101. https://doi.org/10.1006/abio.1998.2809.Suche in Google Scholar PubMed

42. Fleishhacker, ZJ, Rastogi, P, Davis, SR, Aman, DR, Morris, CS, Dyson, RL, et al.. Impact of interfacing near point of care clinical chemistry and hematology analyzers at urgent care clinics at an academic health system. J Pathol Inform 2022;13:100006. https://doi.org/10.1016/j.jpi.2022.100006.Suche in Google Scholar PubMed PubMed Central

43. Kost, GJ, McQueen, MJ. New whole blood analyzers and their impact on cardiac and critical care. Crit Rev Clin Lab Sci 1993;30:153–202. https://doi.org/10.3109/10408369309084667.Suche in Google Scholar PubMed

44. Cate, DM, Adkins, JA, Mettakoonpitak, J, Henry, CS. Recent developments in paper-based microfluidic devices. Anal Chem 2015;87:19–41. https://doi.org/10.1021/ac503968p [Epub 2014 Nov 21].Suche in Google Scholar PubMed

45. Syedmoradi, L, Daneshpour, M, Alvandipour, M, Gomez, FA, Hajghassem, H, Omidfar, K. Point of care testing: the impact of nanotechnology. Biosens Bioelectron 2017;87:373–87. https://doi.org/10.1016/j.bios.2016.08.084 [Epub 2016 Aug 26].Suche in Google Scholar PubMed

46. Ayankojo, AG, Reut, J, Syritski, V. Electrochemically synthesized MIP sensors: applications in healthcare diagnostics. Biosensors (Basel) 2024;14:71. https://doi.org/10.3390/bios14020071.Suche in Google Scholar PubMed PubMed Central

47. Trinh, KTL. Microfluidic biosensors for point-of-care nucleic acid amplification tests. Biosensors (Basel) 2022;13:5. https://doi.org/10.3390/bios13010005.Suche in Google Scholar PubMed PubMed Central

48. Chemosensors Ben Moussa, F, Kutner, W, Beduk, T, Sena-Torralba, A, Mostafavi, E. Electrochemical bio- and chemosensors for cancer biomarkers: natural (with antibodies) versus biomimicking artificial (with aptamers and molecularly imprinted polymers) recognition. Talanta 2024;267:125259. https://doi.org/10.1016/j.talanta.2023.125259 [Epub 2023 Oct 2].Suche in Google Scholar PubMed

49. H Park, R, Jeon, S, Lee, JW, Jeong, J, Kwon, YW, Kim, SH, et al.. Mobile point-of-care device using molecularly imprinted polymer-based chemosensors targeting interleukin-1β biomarker. Biosensors (Basel) 2023;13:1013. https://doi.org/10.3390/bios13121013.Suche in Google Scholar PubMed PubMed Central

50. Bartold, K, Pietrzyk-Le, A, D’Souza, F, Kutner, W. Oligonucleotide analogs and mimics for sensing macromolecular biocompounds. Trends Biotechnol 2019;37:1051–62. https://doi.org/10.1016/j.tibtech.2019.04.003 [Epub 2019 May 17].Suche in Google Scholar PubMed

51. Liu, C, Xu, C, Xue, N, Sun, JH, Cai, H, Li, T, et al.. Enzyme biosensors for point-of-care testing [internet]. In: MEMS sensors – design and application. InTech; 2018.10.5772/intechopen.73249Suche in Google Scholar

52. Muttaqien, SE, Khoris, IM, Suryanggono, J, Sadhukhan, PC, Pambudi, S, Chowdhury, AD, et al.. Point-of-care dengue detection: polydopamine-modified electrode for rapid NS1 protein testing for clinical samples. Mikrochim Acta 2024;191:174. https://doi.org/10.1007/s00604-024-06259-7.Suche in Google Scholar PubMed

53. Survey procedures and interpretive guidelines for laboratories and laboratory services: appendix C. Springfield, VA: US Department of Commerce, National Technical Information Service, 1992: C-122.Suche in Google Scholar

54. Joint Commission on Accreditation of Healthcare Organizations (JCAHO). Comprehensive accreditation manual for pathology and clinical laboratory services. Oakbrook Terrace, IL: JCAHO; 1998.Suche in Google Scholar

55. National committee on clinical laboratory standards. Clinical laboratory technical procedure manuals: approved guideline (GP2–A3), 3rd ed. Villanova, PA: NCCLS, 1996.Suche in Google Scholar

56. Auxter, S. Looking at laboratory quality control in a new light. Clin Lab News 1996;22:57.Suche in Google Scholar

57. Westgard, JO. Strategies for cost-effective quality control. Clin Lab News 1996;22:8–9.Suche in Google Scholar

58. Stavelin, A, Sandberg, S. Analytical performance specifications and quality assurance of point-of-care testing in primary healthcare. Crit Rev Clin Lab Sci 2024;61:164–77. https://doi.org/10.1080/10408363.2023.2262029 [Epub 2023 Oct 1].Suche in Google Scholar PubMed

59. Zhou, Q, Chen, S, Lai, J, Deng, S, Pan, J, Baik, JM, et al.. High rotational speed hand-powered triboelectric nanogenerator toward a battery-free point-of-care detection system. RSC Adv 2021;11:23221–7. https://doi.org/10.1039/d1ra03323a.Suche in Google Scholar PubMed PubMed Central

60. Brümmer, LE, Thompson, RR, Malhotra, A, Shrestha, S, Kendall, EA, Andrews, JR, et al.. Cost-effectiveness of low-complexity screening tests in community-based case-finding for tuberculosis. Clin Infect Dis 2024;78:154–63. https://doi.org/10.1093/cid/ciad501.Suche in Google Scholar PubMed PubMed Central

61. Wei, C, Fu, D, Ma, T, Chen, M, Wang, F, Chen, G, et al.. Sensing patches for biomarker identification in skin-derived biofluids. Biosens Bioelectron 2024;258:116326. https://doi.org/10.1016/j.bios.2024.116326 [Epub 2024 Apr 22].Suche in Google Scholar PubMed

62. Price, CP. Andrew St. John. Point of care testing, 2nd ed. 2004. Chapter 20.Suche in Google Scholar

63. Kurec, A. Trends in point of care testing. Health Manag 2014;14.Suche in Google Scholar

64. Estrela, P, Katarzyna, M. Koczula, Andrea Gallotta; lateral flow assays. Essays Biochem 2016;60:111–20. https://doi.org/10.1042/EBC20150012.Suche in Google Scholar PubMed PubMed Central

65. Walter, B, Greenquist, AC, Howard, WE. 3rd Solid-phase reagent strips for detection of therapeutic drugs in serum by substrate-labeled fluorescent immunoassay. Anal Chem. 1983;55:873–8. https://doi.org/10.1021/ac00257a014.Suche in Google Scholar PubMed

66. Substance Abuse and Mental Health Services Administration. Clinical drug testing in primary care. Rockville, MD: Substance Abuse and Mental Health Services Administration; 2012. Technical Assistance Publication (TAP) 32. HHS Publication No. (SMA) 12-4668.Suche in Google Scholar

67. Yang, J, Wang, K, Xu, H, Yan, W, Jin, Q, Cui, D. Detection platforms for point-of-care testing based on colorimetric, luminescent and magnetic assays: a review. Talanta 2019;202:96–110. https://doi.org/10.1016/j.talanta.2019.04.054 [Epub 2019 Apr 25].Suche in Google Scholar PubMed

68. Nichols, JH. Management of near-patient glucose testing. Endocrinology and metabolism. In: Service training and continuing education; 1994, vol 12:325–34 pp.Suche in Google Scholar

69. LJ Kricka, JY Park, Assay principles in clinical pathology, Editor(s): LM McManus, RN Mitchell, Pathobiology of Human Disease, Academic Press, 2014:3207-21 pp.10.1016/B978-0-12-386456-7.06302-4Suche in Google Scholar

70. Campuzano, S, Pedrero, M, Yáñez-Sedeño, P, Pingarrón, JM. New challenges in point of care electrochemical detection of clinical biomarkers. Sensor Actuator B Chem 2021;345:130349. .https://doi.org/10.1016/j.snb.2021.130349.Suche in Google Scholar

71. Sachdeva, S, Davis, RW, Saha, AK. Microfluidic point-of-care testing: commercial landscape and future directions. Front Bioeng Biotechnol 2021;8. https://doi.org/10.3389/fbioe.2020.602659. https://www.frontiersin.org/articles/10.3389/fbioe.2020.602659,DOI=10.3389/fbioe.2020.602659.ISSN=2296-4185.Suche in Google Scholar PubMed PubMed Central

72. Poul Ravn. Understanding the principles behind blood gas sensor technology. https://acutecaretesting.org/en/articles/understanding-the-principles-behind-blood-gas-sensor-technology [Accessed 28 May 2024].Suche in Google Scholar

73. Kapoor, D, Srivastava, M, Singh, P. Point of care blood gases with electrolytes and lactates in adult emergencies. Int J Crit Illn Inj Sci 2014;4:216–22. https://doi.org/10.4103/2229-5151.141411.Suche in Google Scholar PubMed PubMed Central

74. Point-of-Care (POC) testing for a panel of cardiac markers. Horizon scan report 0033. 2014. Article downloaded from: NIHR Diagnostic Evidence Cooperative Oxford www.oxford.dec.nihr.ac.uk [Accessed 28 May 2024].Suche in Google Scholar

75. Cardiac Troponin T rapid test kit. https://www.biopanda.co.uk/php/products/rapid/troponin_t.phpProductNumber:RAPG-CTNT-001 [Accessed 28 May 2024].Suche in Google Scholar

76. CORTEZ- human Troponin I rapid test serum/WB (cassette) RapiCard InstaTest. http://www.rapidtest.com/pdf/Troponin_I_WB_Serum_166772-1-19_P2(USA)(01-21-2016).pdf [Accessed 28 May 2024].Suche in Google Scholar

77. CORTEZ – Human C-Reactive Protein (CRP). Serum whole blood rapid test (cassette) RapiCard InstaTest. http://www.rapidtest.com/pdf/C-Reactive_Protein_(CRP)_Serum_WB_Plasma_%20166800-1-44%20(2017-3-30).pdf [Accessed 28 May 2024].Suche in Google Scholar

78. Procalcitonin RapiCard (S/P). http://www.rapidtest.com/pdf/Procalcitonin%20RapiCard_110512-1-44_(2017-08-17).pdf [Accessed 28 May 2024].Suche in Google Scholar

79. Tonyushkina, K, Nichols, JH. Glucose meters: a review of technical challenges to obtaining accurate results. J Diabetes Sci Technol 2009;3:971–80. https://doi.org/10.1177/193229680900300446.Suche in Google Scholar PubMed PubMed Central

80. Reddy, N, Verma, N, Dungan, K. Monitoring technologies- continuous glucose monitoring, mobile technology, biomarkers of glycemic control. In: Feingold, KR, Anawalt, B, Blackman, MR, et al., editors. Endotext [internet], [Updated 2023 Jul 8]. South Dartmouth (MA): MDText.com, Inc.; 2000. Available from: https://www.ncbi.nlm.nih.gov/books/NBK279046/.Suche in Google Scholar

81. Fellows, SE, Cipriano, GC. Variation between point-of-care and laboratory HbA1c testing in clinical practice. Puert Rico Health Sci J 2019;38:189–91.Suche in Google Scholar

82. Human total IgE rapid test (serum) RapiCard InstaTest. http://www.rapidtest.com/pdf/IgE_15150-1_(01-14-2016).pdf [Accessed 28 May 2024].Suche in Google Scholar

83. 9-Panel drug test (strip). http://www.rapidtest.com/pdf/Multiple_Drug_RapiCard(01-28-2016).pdf [Accessed 28 May 2024].Suche in Google Scholar

84. Gnoth, C, Johnson, S. Strips of hope: accuracy of home pregnancy tests and new developments. Geburtshilfe Frauenheilkd 2014;74:661–9. https://doi.org/10.1055/s-0034-1368589.Suche in Google Scholar PubMed PubMed Central

85. Accutest ovulation test cassette. http://www.accu-test.com/ovulation-test-cassette.html [Accessed 28 May 2024].Suche in Google Scholar

86. Urine menopause test device. https://www.atlas-medical.com/upload/productFiles/207002003/FSH%20Package%20Insert.pdf [Accessed 28 May 2024].Suche in Google Scholar

87. Urine dipstick test. https://www.mn-net.com/urine-test-strips-information [Accessed 28 May 2024].Suche in Google Scholar

88. Vitamin D RapiCard (whole blood). http://www.rapidtest.com/pdf/Vitamin%20D%20RapiCard%20(WB)%20(07-18-2017).pdf [Accessed 28 May 28 2024].Suche in Google Scholar

89. Dale, RA, Jensen, LH, Krantz, MJ. Comparison of two point-of-care lipid analyzers for use in global cardiovascular risk assessments. Ann Pharmacother 2008;42:633–9. https://doi.org/10.1345/aph.1K688 [Epub 2008 Apr 15].Suche in Google Scholar PubMed

90. Parsons, M, Newman, DJ, Pugia, M, Newall, RG, Price, CP. Performance of a reagent strip device for quantitation of the urine albumin: creatinine ratio in a point of care setting. Clin Nephrol 1999;51:220–7.Suche in Google Scholar

91. Guy, M, Newall, R, Borzomato, J, Kalra, PA, Price, C. Diagnostic accuracy of the urinary albumin: creatinine ratio determined by the CLINITEK microalbumin and DCA 2000+ for the rule-out of albuminuria in chronic kidney disease. Clin Chim Acta 2009;399:54–8. https://doi.org/10.1016/j.cca.2008.09.006 [Epub 2008 Sep 14].Suche in Google Scholar PubMed

92. Malhotra, BD, Chaubey, A. Biosensors for clinical diagnostics industry. Sensor Actuator B Chem 2003;91:117–27. https://doi.org/10.1016/s0925-4005(03)00075-3.Suche in Google Scholar

93. Fossati, P, Prencipe, L, Berti, G. Use of 3, 5-dichloro-2-hydroxybenzenesulfonic acid/4-aminophenazone chromogenic system in direct enzymic assay of uric acid in serum and urine. Clin Chem 1980;26:227–31. https://doi.org/10.1093/clinchem/26.2.0227.Suche in Google Scholar

94. Van Rijn, JL, van Landeghem, AA, Goldschmidt, HM. Evaluation of a bench-top nephelometric immunoassay analyzer. J Clin Lab Anal 1991;5:3–13. https://doi.org/10.1002/jcla.1860050103.Suche in Google Scholar PubMed

95. Wolf, PL. Biochemical diagnosis of liver disease. Indian J Clin Biochem 1999;14:59–90. https://doi.org/10.1007/BF02869152.Suche in Google Scholar PubMed PubMed Central

96. Simpson, G. Accuracy and precision of breath-alcohol measurements for a random subject in the postabsorptive state. Clin Chem 1987;33:261–8. https://doi.org/10.1093/clinchem/33.2.261.Suche in Google Scholar

97. Ezegbogu, MO, Ugwoke, CU, Ibrahim, Z, Abdulsalam, K. Thyroid stimulating hormone (TSH) estimation using point of care testing devices: pitfalls and opportunities for improvement. Niger J Basic Clin Sci 2022;19:8–14. https://doi.org/10.4103/njbcs.njbcs_47_21.Suche in Google Scholar

98. Khelifa, L, Hu, Y, Jiang, N, Yetisen, AK. Lateral flow assays for hormone detection. Lab Chip 2022;22:2451–75. https://doi.org/10.1039/d1lc00960e.Suche in Google Scholar PubMed

99. https://www.cdc.gov/mmwr/preview/mmwrhtml/rr5413a1.htm.Suche in Google Scholar

100. Liikanen, E, Lehto, L. Training of nurses in point-of-care testing: a systematic review of the literature. J Clin Nurs 2013;22:2244–52. https://doi.org/10.1111/jocn.12235 [Epub 2013 May 16].Suche in Google Scholar PubMed

101. Meier, FA, Jones, BA. Point-of-care testing error: sources and amplifiers, taxonomy, prevention strategies, and detection monitors. Arch Pathol Lab Med 2005;129:1262–7. https://doi.org/10.5858/2005-129-1262-PTESAA.Suche in Google Scholar PubMed

102. Shaw, JLV. Practical challenges related to point of care testing. Pract Lab Med 2015;4:22–9. https://doi.org/10.1016/j.plabm.2015.12.002. .Suche in Google Scholar PubMed PubMed Central

103. Lewandrowski, K. How the clinical laboratory and the emergency department can work together to move patients through quickly. Clin Leader Manag Rev 2004;18:155–9.Suche in Google Scholar

104. Yenice, S. Training and competency strategies for point-of-care testing. EJIFCC 2021;32:167–78.Suche in Google Scholar

105. Dyer, K, Nichols, JH, Taylor, M, Miller, R, Saltz, J. Development of a universal connectivity and data management system. Crit Care Nurs Q 2001;24:25–38. quiz 2 p following 75. https://doi.org/10.1097/00002727-200105000-00006.Suche in Google Scholar PubMed

106. AACC guidance document on management of point-of-care testing. .4.2020. https://www.aacc.org/science-and-research/aacc-academy-guidance/management-of-point-of-care-testing [Accessed 30 May 2024].Suche in Google Scholar

107. Larkins, MC, Thombare, A. Point-of-Care testing. 2023 may 29. In: . StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2024.Suche in Google Scholar

108. Van Der Pol, B. Opportunities and challenges of point of care testing paradigms in the post-COVID era. Expert Rev Mol Diagn 2024;24:135–7. https://doi.org/10.1080/14737159.2024.2330774 [Epub 2024 Mar 19].Suche in Google Scholar PubMed

109. Otto, C, Chen, D. Point of care molecular testing: current state and opportunities for diagnostic stewardship. Clin Lab Med 2024;44:23–32. https://doi.org/10.1016/j.cll.2023.10.010 [Epub 2023 Nov 15].Suche in Google Scholar PubMed

Received: 2025-01-31
Accepted: 2025-03-13
Published Online: 2025-04-04

© 2025 Walter de Gruyter GmbH, Berlin/Boston

Artikel in diesem Heft

  1. Frontmatter
  2. Reviews
  3. Navigating nephropathy and nephrotoxicity: understanding pathophysiology unveiling clinical manifestations, and exploring treatment approaches
  4. Incretin-based therapies: advancements, challenges, and future directions in type 2 diabetes management
  5. Point-of-care testing: revolutionizing clinical biochemistry using decentralized diagnostics
  6. The impact of heavy metals exposure on male fertility: a scoping review of human studies
  7. Glucagon in glucose homeostasis and metabolic disease: from physiology to therapeutics
  8. The efficacy of dietary supplements on health status and performance of football players: a systematic review
  9. Original Articles
  10. Factors affecting self-care in heart failure patients: a cross-sectional study
  11. Physiological regulation of moderate-intensity exercise in improving the biomarkers visfatin and myonectin as a modulator of increasing metabolic performance in obese
  12. A comparative study of heart rate variability (HRV) among adult hypertensive and normotensive subjects in the supine position
  13. Elevated seminal plasma leptin may correlate with varicocele presence and BMI
  14. Clinical significance of detectable blood lead and cadmium in the Sarno river basin population: results from the PREVES-STOP study
  15. Outcomes of systemic thrombolysis with reteplase in high-risk acute pulmonary embolism
  16. The pharmacokinetics and comparative bioavailabilty of oral and subcutaneous semaglutide in healthy volunteers
  17. Short Communications
  18. Approaching a phenomenal contradiction in acid–base physiology
  19. Current trends and innovations in oral and maxillofacial surgery
  20. Letter to the Editor
  21. The need for quality certification for urological apps
Heruntergeladen am 8.9.2025 von https://www.degruyterbrill.com/document/doi/10.1515/jbcpp-2025-0029/html?recommended=sidebar
Button zum nach oben scrollen